ATE442378T1 - Substituierte wt1-peptide - Google Patents

Substituierte wt1-peptide

Info

Publication number
ATE442378T1
ATE442378T1 AT03797688T AT03797688T ATE442378T1 AT E442378 T1 ATE442378 T1 AT E442378T1 AT 03797688 T AT03797688 T AT 03797688T AT 03797688 T AT03797688 T AT 03797688T AT E442378 T1 ATE442378 T1 AT E442378T1
Authority
AT
Austria
Prior art keywords
peptides
asn
polynucleotides
substituted
leu
Prior art date
Application number
AT03797688T
Other languages
English (en)
Inventor
Haruo Sugiyama
Masashi Gotoh
Hideo Takasu
Fumio Samizo
Naoto Kusunose
Masashi Nakatsuka
Original Assignee
Int Inst Cancer Immunology Inc
Chugai Pharmaceutical Co Ltd
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Int Inst Cancer Immunology Inc, Chugai Pharmaceutical Co Ltd, Dainippon Sumitomo Pharma Co filed Critical Int Inst Cancer Immunology Inc
Application granted granted Critical
Publication of ATE442378T1 publication Critical patent/ATE442378T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Seasonings (AREA)
AT03797688T 2002-09-20 2003-09-19 Substituierte wt1-peptide ATE442378T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002275264 2002-09-20
PCT/JP2003/011974 WO2004026897A1 (ja) 2002-09-20 2003-09-19 Wt1置換型ペプチド

Publications (1)

Publication Number Publication Date
ATE442378T1 true ATE442378T1 (de) 2009-09-15

Family

ID=32025026

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03797688T ATE442378T1 (de) 2002-09-20 2003-09-19 Substituierte wt1-peptide

Country Status (8)

Country Link
US (1) US7378384B2 (de)
EP (1) EP1548028B1 (de)
JP (1) JP4480580B2 (de)
AT (1) ATE442378T1 (de)
AU (1) AU2003264514A1 (de)
DE (1) DE60329201D1 (de)
ES (1) ES2331305T3 (de)
WO (1) WO2004026897A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4932199A (en) * 1998-07-31 2000-02-21 Haruo Sugiyama Cancer antigens based on tumor suppressor gene wt1 product
CN1281625C (zh) * 2001-03-22 2006-10-25 株式会社癌免疫研究所 经修饰的wt1肽
EP1550453B1 (de) * 2002-09-12 2015-05-27 International Institute of Cancer Immunology, Inc. Präparat eines peptids eines krebs-antigens
WO2005045027A1 (ja) 2003-11-05 2005-05-19 International Institute Of Cancer Immunology, Inc. Wt1由来のhla−dr結合性抗原ペプチド
PT1731605E (pt) * 2004-03-31 2010-04-14 Int Inst Cancer Immunology Inc Péptidos antigénicos de cancro derivados de wt1
WO2005116056A1 (ja) * 2004-05-26 2005-12-08 Green Peptide Co., Ltd. 副甲状腺ホルモン関連タンパク質のhla-a24またはhla-a2結合ペプチド
SI1961761T1 (sl) 2005-11-30 2010-12-31 Int Inst Cancer Immunology Inc Nove peptidne spojine iz Wilmsovega tumorja
MX352947B (es) 2007-02-27 2017-12-14 Int Inst Cancer Immunology Inc Metodo para activacion de celula t auxiliar y composicion para usarse en el metodo.
US9117133B2 (en) * 2008-06-18 2015-08-25 Spectral Image, Inc. Systems and methods for hyperspectral imaging
AT508569A1 (de) * 2009-07-23 2011-02-15 Affiris Ag Pharmaceutical compound
SG189287A1 (en) 2010-10-05 2013-05-31 Int Inst Cancer Immunology Inc Method for activating helper t cell
ES2785081T3 (es) * 2011-04-01 2020-10-05 Memorial Sloan Kettering Cancer Center Anticuerpos biespecíficos similares a receptores de células T específicos para un péptido de WT1 presentado por HLA-A2
EP2868325B1 (de) 2012-07-02 2017-11-01 Sumitomo Dainippon Pharma Co., Ltd. Transdermales krebs-antigen-peptidpräparat
EP2703483A1 (de) 2012-08-29 2014-03-05 Affiris AG PCSK9 Peptidimpfstoff
AR094026A1 (es) 2012-12-17 2015-07-08 Otsuka Pharma Co Ltd Metodo para activar la celula t helper
CA2840941A1 (en) 2013-02-05 2014-08-05 Nitto Denko Corporation Wt1 peptide cancer vaccine composition for transdermal administration
CA2841014A1 (en) 2013-02-05 2014-08-05 Nitto Denko Corporation Tape preparation of wt1 peptide cancer vaccine for transdermal administration
CN103961307B (zh) 2013-02-05 2019-11-29 日东电工株式会社 经皮给予用wt1肽癌症疫苗组合物
CN103961702B (zh) 2013-02-05 2019-04-09 日东电工株式会社 粘膜给予用wt1肽癌症疫苗组合物
EP2974734B1 (de) 2013-03-12 2018-10-10 Sumitomo Dainippon Pharma Co., Ltd. Flüssige, wässrige zusammensetzung
WO2014157692A1 (ja) 2013-03-29 2014-10-02 大日本住友製薬株式会社 Wt1抗原ペプチドコンジュゲートワクチン
WO2015077717A1 (en) 2013-11-25 2015-05-28 The Broad Institute Inc. Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status
WO2015085147A1 (en) 2013-12-05 2015-06-11 The Broad Institute Inc. Polymorphic gene typing and somatic change detection using sequencing data
JP6740127B2 (ja) * 2013-12-06 2020-08-12 ザ・ブロード・インスティテュート・インコーポレイテッド 新生物ワクチン用製剤
JP7060324B2 (ja) 2013-12-20 2022-04-26 ザ・ブロード・インスティテュート・インコーポレイテッド ネオ抗原ワクチンによる併用療法
US10975442B2 (en) 2014-12-19 2021-04-13 Massachusetts Institute Of Technology Molecular biomarkers for cancer immunotherapy
EP3234130B1 (de) 2014-12-19 2020-11-25 The Broad Institute, Inc. Verfahren zum profiling vom t-zell-rezeptor-repertoire
JP6913032B2 (ja) 2015-05-20 2021-08-04 ザ・ブロード・インスティテュート・インコーポレイテッド 共通ネオ抗原
WO2018101309A1 (ja) 2016-11-30 2018-06-07 大日本住友製薬株式会社 Wt1ヘルパーペプチド及びこれと癌抗原ペプチドコンジュゲート体との組合せ
EP3574116A1 (de) 2017-01-24 2019-12-04 The Broad Institute, Inc. Zusammensetzungen und verfahren zum nachweis einer mutanten variante eines polynukleotids
EP3604325A4 (de) 2017-03-30 2021-01-13 Sumitomo Dainippon Pharma Co., Ltd. Wt1-krebs-antigen-peptid und peptid-konjugat-körper damit
JP7162675B2 (ja) 2018-09-28 2022-10-28 住友ファーマ株式会社 注射用組成物
US12440546B2 (en) 2018-10-05 2025-10-14 International Institute Of Cancer Immunology, Inc. Composition for preventing or treating benign tumor
TWI875736B (zh) 2019-02-28 2025-03-11 日商住友製藥股份有限公司 選擇可期待用於治療或預防癌之醫藥組合物之效果之對象之方法
KR20230009426A (ko) 2020-05-12 2023-01-17 스미토모 파마 가부시키가이샤 암을 처치하기 위한 의약 조성물
TW202315645A (zh) 2021-08-12 2023-04-16 日商癌免疫研究所股份有限公司 用以處置或預防癌症之醫藥組合物及方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4932199A (en) 1998-07-31 2000-02-21 Haruo Sugiyama Cancer antigens based on tumor suppressor gene wt1 product
KR100752065B1 (ko) 1998-09-30 2007-08-28 코릭사 코포레이션 Wt1 특이적 면역요법용 조성물 및 방법
CN1281625C (zh) 2001-03-22 2006-10-25 株式会社癌免疫研究所 经修饰的wt1肽
EP1447092A4 (de) 2001-09-28 2007-07-11 Haruo Sugiyama Neues verfahren zur induktion von antigenspezifischen t-zellen
US8735357B2 (en) * 2001-09-28 2014-05-27 International Institute Of Cancer Immunology, Inc. Method of inducing antigen-specific T cells

Also Published As

Publication number Publication date
AU2003264514A1 (en) 2004-04-08
EP1548028A4 (de) 2006-03-15
AU2003264514A8 (en) 2004-04-08
WO2004026897A1 (ja) 2004-04-01
US7378384B2 (en) 2008-05-27
ES2331305T3 (es) 2009-12-29
JP4480580B2 (ja) 2010-06-16
EP1548028A1 (de) 2005-06-29
DE60329201D1 (de) 2009-10-22
JPWO2004026897A1 (ja) 2006-01-19
US20060205667A1 (en) 2006-09-14
EP1548028B1 (de) 2009-09-09

Similar Documents

Publication Publication Date Title
DE60329201D1 (de) Substituierte wt1-peptide
CA2489227A1 (en) Hla-a24-restricted cancer antigen peptides
DK1531791T3 (da) Forebyggelse og begrænsning af iskæmi
AR036196A1 (es) Agentes de contraste multimericos dirigidos a base de peptidos
CO5700784A2 (es) Polipeptidos de virus de papiloma humano y composiciones in- munogenas
DE69942035D1 (de) Menschliches parathyroidhormon, modifikationen, herstellung und verwendung
ATE417595T1 (de) Keratin-bindende polypeptide
AR006517A1 (es) Polipeptido que alcanza un total de alrededor de 30 aminoacidos; sustancia, peptidomimetico y composicion farmaceutica resultantes; usos del polipeptidoy proceso para la sintesis del polipeptido.
CA2097192A1 (en) Bombesin antagonists
RU2010111139A (ru) Комбинированная терапия рака поджелудочной железы с использованием антигенного пептида и химиотерапевтического средства
ATE536878T1 (de) Herstellung einer therapeutischen zusammensetzung
EA201100459A1 (ru) Композиции, включающие интерлейкин-1 и пептиды
EP0783521B1 (de) D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
IE65533B1 (en) Hemoregulatory peptides
AU671989B2 (en) Treatment of tropical spastic paresis with peptide T
ATE481420T1 (de) Il-21-derivate
DE60332425D1 (de) 5t4-antigen-peptidepitope der mhc klasse ii
ATE245168T1 (de) Peptide, die anti-zellanhaftungsaktivität aufweisen
JP2021531246A5 (de)
ATE371737T1 (de) Proteaseresistente flint-analoge
ATE124955T1 (de) Substrat-peptide.
WO2004074312A3 (en) Tryptophyllin peptides and uses thereof
JP2004505616A5 (de)
DK1778271T3 (da) Peptid til behandling af herpesvirusinfektioner
US5776900A (en) Hemoregulatory peptides

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties